Altimmune, Inc.
ALT
$3.47
$0.051.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.88% | 14.14% | -13.13% | 15.55% | -1.47% |
| Total Depreciation and Amortization | -3.70% | -10.00% | 3.45% | -12.12% | -10.81% |
| Total Amortization of Deferred Charges | -251.33% | 94.83% | -- | -- | -- |
| Total Other Non-Cash Items | 28.83% | 37.82% | -24.59% | 37.06% | 15.86% |
| Change in Net Operating Assets | 2.41% | 1,590.43% | 134.38% | -124.68% | 138.52% |
| Cash from Operations | -63.47% | 38.52% | -14.90% | 7.80% | 32.65% |
| Capital Expenditure | -- | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 46.99% | -247.67% | 2,082.30% | -137.42% | 1,036.95% |
| Cash from Investing | 46.99% | -247.69% | 2,082.10% | -137.42% | 1,036.95% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 55.39% | 4.87% | 8.32% | 246.21% | 3,635.93% |
| Repurchase of Common Stock | -- | 100.00% | 99.12% | -33,800.00% | 50.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -52.17% | 44.19% | -361.60% | -- | -- |
| Cash from Financing | 106.18% | -24.68% | 53.12% | 238.31% | 3,691.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.66% | -190.95% | 1,000.35% | 123.37% | 121.25% |